Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026)
Gilead Sciences' (GILD) quarterly Long-Term Deferred Tax came in at $1.8 billion in Q1 2026, down 31.3% YoY from $2.6 billion in Q1 2025, and down 10.03% on a QoQ basis from $2.0 billion in Q4 2025.
Gilead Sciences (GILD) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 12 years of Long-Term Deferred Tax data on file, last reported at $1.8 billion in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 31.3% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (down 31.3% YoY) and the FY2025 annual result came in at $2.0 billion, down 17.41% from the prior year.
- Long-Term Deferred Tax slipped to $1.8 billion in Q1 2026, from $2.0 billion in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $2.7 billion in Q2 2025 to a low of $1.8 billion in Q1 2026.
- A 3-year average of $2.2 billion and a median of $2.2 billion in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2025 — Long-Term Deferred Tax fell 17.41% — and 2026, when it plunged 31.3%.
- Tracing GILD's Long-Term Deferred Tax over 3 years: stood at $2.4 billion in 2024, then decreased by 17.41% to $2.0 billion in 2025, then fell by 10.03% to $1.8 billion in 2026.
- The last three Long-Term Deferred Tax figures came in at $1.8 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.49 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | 1.96 Bn |
| Sep 30, 2025 | 2.00 Bn |
| Jun 30, 2025 | 2.72 Bn |
| Mar 31, 2025 | 2.57 Bn |
| Dec 31, 2024 | 2.38 Bn |
| Sep 30, 2017 | 1.15 Bn |
| Jun 30, 2017 | 1.14 Bn |
| Mar 31, 2017 | 1.21 Bn |
| Dec 31, 2016 | 1.26 Bn |
| Sep 30, 2016 | 481.00 Mn |
| Jun 30, 2016 | 433.00 Mn |
| Mar 31, 2016 | 292.00 Mn |
| Dec 31, 2015 | 1.46 Bn |
| Sep 30, 2015 | 291.00 Mn |
| Jun 30, 2015 | 177.00 Mn |
| Mar 31, 2015 | 205.00 Mn |
| Dec 31, 2014 | 1.06 Bn |
| Sep 30, 2014 | 163.72 Mn |